http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 1129 reviews. 1129 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Atemperator LP

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only.
You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Atemperator LP uses and description

Sort by popularity
Atemperator LP - Used for: Treating certain seizure disorders. It may also be used for other conditions as determined by your doctor.

Atemperator LP is an anticonvulsant. It works by increasing the amount of a certain chemical in the brain.

Atemperator LP affects chemicals in the body that may be involved in causing seizures.

Atemperator LP is used to treat various types of seizure disorders. Atemperator LP is sometimes used together with other seizure medications.

Atemperator LP may also be used for purposes not listed in this medication guide.

Atemperator LP is an anticonvulsant and mood-stabilizing drug used primarily in the treatment of epilepsy and bipolar disorder. It is also used to treat migraine headaches and schizophrenia. In epileptics, Atemperator LP is used to control absence seizures, tonic-clonic seizures (grand mal), complex partial seizures, and the seizures associated with Lennox-Gastaut syndrome. Atemperator LP is believed to affect the function of the neurotransmitter GABA (as a GABA transaminase inhibitor) in the human brain. Atemperator LP dissociates to the valproate ion in the gastrointestinal tract. Atemperator LP has also been shown to be an inhibitor of an enzyme called histone deacetylase 1 (HDAC1). HDAC1 is needed for HIV to remain in infected cells. A study published in August 2005 revealed that patients treated with Atemperator LP in addition to highly active antiretroviral therapy (HAART) showed a 75% reduction in latent HIV infection.

Oral Prophylaxis of migraine

Adult: As valproate semisodium: Initially, 250 mg bid. Max: 1 g daily.

Elderly: Initiate at lower dose and increase slowly. Renal impairment: Dose adjustments may be needed. Hepatic impairment: Avoid. Oral Acute manic episodes of bipolar disorder

Adult: As valproate semisodium: Initially, 750 mg daily in divided doses, increase as fast as possible to achieve optimal response or desired range of trough plasma concentrations between 50-125 mcg/ml. Max: 60 mg/kg daily.

Elderly: Initiate at lower dose and increase slowly. Renal impairment: Dose adjustments may be needed. Hepatic impairment: Avoid. Oral Complex partial seizures

Adult: As monotherapy, conversion to monotherapy or adjunctive therapy: Given as Atemperator LP or valproate semisodium, initially 10-15 mg/kg/day in 2-4 divided doses, increased by 5-10 mg/kg/wk. Max: 30mg/kg/day. Given as sodium valproate, 600 mg daily in 2 divided doses, increased by 200 mg every 3 days. Usual range: 1-2 g daily (20 - 30 mg/kg daily). Max: 2.5 g daily.

Child: As monotherapy, conversion to monotherapy or adjunctive therapy: Given as sodium valproate: >20kg: 400 mg/day in 2 divided doses, increased gradually until control achieved. Usual range: 20-30 mg/kg/day. Max: 35mg/kg/day. <20kg: 20mg/kg daily in 2 divided doses, increased to 40mg/kg daily in severe cases, with serum Atemperator LP monitoring. Monitor clinical chemistry and haematological parameters if doses >40mg/kg daily used. Given as Atemperator LP or valproate semisodium for ≥10 yr: initially, 10-15 mg/kg/day in 2-4 divided doses, increased by 5-10 mg/kg/wk. Max: 30mg/kg/day.

Elderly: Initiate at lower dose and increase slowly. Renal impairment: Dose adjustments may be needed. Hepatic impairment: Avoid. Oral Simple and complex absence seizures

Adult: As monotherapy, conversion to monotherapy or adjunctive therapy: Given as Atemperator LP or valproate semisodium, initially 15 mg/kg/day in 2-4 divided doses, increased by 5-10 mg/kg/wk. Max: 30 mg/kg/day.

Child: As monotherapy, conversion to monotherapy or adjunctive therapy: Given as sodium valproate: >20kg: 400 mg/day in 2 divided doses, increased gradually until control achieved. Usual range: 20-30 mg/kg/day. Max: 35mg/kg/day. <20kg: 20mg/kg daily in 2 divided doses, increased to 40mg/kg daily with serum Atemperator LP monitoring in severe cases. Monitor clinical chemistry and haematological parameters if > 40mg/kg daily. Given as Atemperator LP or valproate semisodium ≥10 yr: Initially 15 mg/kg/day in 2-4 divided doses, increased by 5-10 mg/kg/wk. Max: 30mg/kg/day.

Elderly: Initiate at lower dose and increase slowly. Renal impairment: Dose adjustments may be needed. Hepatic impairment: Avoid. Oral Bipolar disorder

Adult: As valpromide: 900-1800 mg daily in 2 divided doses. Usual dose: 1200 mg daily. Initiate at required dose or dosage may be increased every 2-3 days to reach optimal dose in 2 wk with simultaneous and progressive dose reduction of concurrent psychotropic drugs. Intravenous Complex partial seizures

Adult: Given as sodium valproate: Initially 400-800 mg daily increasing by 150-300 mg every 3 days until control is achieved. Usual dose: 20-30 mg/kg/day. Daily doses to be given in 3-4 divided doses. Each dose to be given as slow IV Inj over 3-5 minutes or by infusion in 0.9% saline or 5% dextrose over 60 minutes (Max rate: 20 mg/minute). Max: 2.5 g daily.

Child: Given as sodium valproate: Initially 300mg/day increased until control is achieved. Usual range: 20-30 mg/kg/day. Max: 40 mg/kg/day with plasma Atemperator LP levels monitoring.

Elderly: Initiate at lower dose and increase slowly. Renal impairment: Dose adjustments may be needed. Hepatic impairment: Avoid. Intravenous Simple and complex absence seizures

Adult: Given as sodium valproate: Initially 400-800 mg daily increasing by 150-300 mg every 3 days until control is achieved. Usual dose: 20-30 mg/kg/day. Daily doses to be given in 3-4 divided doses. Each dose to be given as slow IV Inj over 3-5 minutes or by infusion in 0.9% saline or 5% dextrose over 60 minutes (Max rate: 20 mg/minute). Max: 2.5 g daily.

Child: Given as sodium valproate: Initially 300mg/day increased until control is achieved. Usual range: 20-30 mg/kg/day. Max: 40 mg/kg/day with plasma Atemperator LP levels monitoring.

Elderly: Initiate at lower dose and increase slowly. Renal impairment: Dose adjustments may be needed. Hepatic impairment: Avoid.

Indications:

Adult: PO Migraine prophylaxis As valproate semisodium: Initial: 250 mg twice daily. Max: 1 g/day. Acute manic episodes of bipolar disorder As valproate semisodium: Initial: 750 mg/day in divided doses, increase as needed based on response. Max: 60 mg/kg/day. Complex partial seizures As Atemperator LP or valproate semisodium: Initial: 10-15 mg/kg/day in 2-4 divided doses, increase if needed. Max: 30 mg/kg/day. As Na valproate: 600 mg/day in 2 divided doses, increase if needed. Usual: 1-2 g/day. Max: 2.5 g/day. Simple and complex absence seizures As Atemperator LP or valproate semisodium: As monotherapy, conversion to monotherapy or adjunctive therapy: Initial: 15 mg/kg/day in 2-4 divided doses, increase if needed. Max: 30 mg/kg/day. Bipolar disorder As valpromide: 0.9-1.8 g/day in 2 divided doses. Usual: 1.2 g/day. May increase slowly to reach optimal dose w/ simultaneous and progressive dose reduction of concurrent psychotropic drugs. IV Complex partial seizures; Simple and complex absence seizures As Na valproate: Initial: 400-800 mg/day, increase slowly until control is achieved. Usual: 20-30 mg/kg/day. Daily doses to be given in 3-4 divided doses. Max: 2.5 g/day.

Atemperator LP is used to treat epilepsy (also known as fits or seizures). It may be used on its own or together with other epilepsy medicines. Atemperator LP may also be used to treat other conditions as decided by your doctor.

Atemperator LP Syrup (Valproic Acid Oral Solution, USP) is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Atemperator LP Syrup (Valproic Acid Oral Solution, USP) is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. Simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. Complex absence is the term used when other signs are also present. SEE WARNINGS

Active ingredients: Valproic Acid
Unit description, dosagePrice, USD
Tablet, Extended Release; Oral; Valproic Acid (Magnesium Valproate) 300 mg
Tablet, Extended Release; Oral; Valproic Acid (Magnesium Valproate) 600 mg

List of atemperator lp brand and generic drugs

Baldeken-R (Japan)
Biproate-CR
Biproate-CR 133+58 Tablet$ 0.05
Biproate-CR 333+145 Tablet$ 0.13
Biproate-CR 200+87 Tablet$ 0.08
Bruceine D
Cebotval (Japan)
Cebotval 200 mg x 1000's
Cereb (Japan)
Convulex (Austria, Belgium, Bulgaria, Chile, Czech Republic, Estonia, Georgia, Germany, Hungary, Latvia, Lithuania, Luxembourg, Poland, Romania, Russian Federation, Singapore, Slovakia, South Africa, Switzerland, Taiwan, Turkey, United Kingdom)
Capsule, Enteric Coated; Oral; Valproic Acid 150 mg
Capsule, Enteric Coated; Oral; Valproic Acid 200 mg
Capsule, Enteric Coated; Oral; Valproic Acid 300 mg
Capsule, Enteric Coated; Oral; Valproic Acid 500 mg
Drops; Oral; Valproic Acid (Valproate Sodium) 300 mg / ml
Injectable; Injection; Valproic Acid 100 mg / ml
Syrup; Oral; Valproic Acid (Valproate Sodium) 250 mg / 5 ml
Tablet, Prolonged Release; Oral; Valproic Acid (Valproate Sodium) 300 mg
Tablet, Prolonged Release; Oral; Valproic Acid (Valproate Sodium) 500 mg
Convulex 200 mg x 100's$ 40.00
Convulex 300 mg x 100's$ 56.00
Convulex 500 mg x 100's$ 93.00
Convulex 50 mg/1 mL x 100 mL x 1's$ 13.00
Convulex 150 mg x 100's
Convulex 50 mg/1 mL x 1 mL
Convulex 50 mg/1 mL x 100 mL
Convulsofin (Bulgaria, Georgia, Germany, Russian Federation)
Drops; Oral; Valproic Acid (Valproate Calcium)
Tablet; Oral; Valproic Acid (Valproate Calcium) 300 mg
Criam (Mexico)
Solution; Oral; Valproic Acid (Magnesium Valproate) 1 g / 5 ml
Suspension; Oral; Valproic Acid (Magnesium Valproate) 200 mg / 5 ml
Tablet, Enteric Coated; Oral; Valproic Acid (Magnesium Valproate) 200 mg
Tablet, Enteric Coated; Oral; Valproic Acid (Magnesium Valproate) 400 mg
Tablet, Enteric Coated; Oral; Valproic Acid (Magnesium Valproate) 500 mg
Cryoval
Dépakine (Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Congo, Cote D'ivoire, France, Gabon, Guinea, Iceland, Madagascar, Mali, Mauritania, Mauritius, Niger, Senegal, Togo, Tunisia, Zaire)
Dépakote (France)
Delepsine (Denmark)
Depa
Depacon (United States)
Injectable; Injection; Valproate Sodium 100 mg / ml
Depacon 500 mg/5 mL x 10's$ 479.69
5 milliliter in 1 vial, single-dose
Depakene (Argentina, Brazil, Canada, Chile, Colombia, Costa Rica, El Salvador, Guatemala, Honduras, Indonesia, Japan, Nicaragua, Panama, Peru, Philippines, United States)
Capsule; Oral; Valproic Acid 250 mg
Capsule; Oral; Valproic Acid 500 mg
Syrup; Oral; Valproic Acid 250 mg / 5 ml

Show all Atemperator LP generic names
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer